FDA lifts hold on Concert Pharma's hair loss drug

(Reuters) - Concert Pharmaceuticals Inc said on Monday the U.S. Food and Drug Administration lifted the clinical hold on a mid-stage study testing its drug to treat alopecia areata, a type of hair loss.